Income from Continuous Operations: A company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change.
Catalyst Pharmaceuticals, Inc. (CPRX) had Income from Continuous Operations of $214.33M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$588.99M |
|
$214.33M |
|
$87.25M |
|
$501.74M |
|
$331.21M |
|
$257.78M |
|
$25.74M |
|
$283.51M |
|
$283.51M |
|
$214.33M |
|
|
Income from Continuous Operations |
$214.33M |
$214.33M |
|
$214.33M |
|
$257.78M |
|
$295.65M |
|
122.29M |
|
127.26M |
|
$1.75 |
|
$1.68 |
|
| Balance Sheet Financials | |
$894.03M |
|
$1.04M |
|
$209.95M |
|
$1.10B |
|
$147.15M |
|
-- |
|
$2.56M |
|
$149.71M |
|
$954.27M |
|
$822.59M |
|
$954.27M |
|
122.51M |
|
| Cash Flow Statement Financials | |
$208.67M |
|
$-0.06M |
|
$-16.99M |
|
$517.55M |
|
$709.17M |
|
$191.62M |
|
$24.78M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.08 |
|
-- |
|
-- |
|
-- |
|
-- |
|
85.19% |
|
43.77% |
|
43.77% |
|
50.20% |
|
48.14% |
|
36.39% |
|
$208.61M |
|
-- |
|
-- |
|
-- |
|
0.53 |
|
2.35 |
|
4.66 |
|
78.38 |
|
22.46% |
|
26.05% |
|
19.41% |
|
22.46% |
|
$7.79 |
|
$1.64 |
|
$1.64 |
|